I-iSolveLife ene-Redikall iyinhlanganisela eyingqayizivele futhi enamandla enikeza indlela ebanzi ekuthuthukisweni komuntu siqu nokochwepheshe. I-Redikall iwuhlelo oluphelele esiza abantu ukuthi babone futhi baxazulule izimbangela zezinkinga zabo, kuyilapho i-iSolveLife ihlinzeka ngamathuluzi nezisetshenziswa zokubasekela ohambweni lwabo lwenguquko.
I-iSolveLife yenza kube lula ukufunda nokusebenzisa i-Redikall. Uhlelo lokusebenza lunikeza izici ezihlukahlukene, kuhlanganise:
Ukuzindla okuqondisiwe: i-iSolveLife inikeza izinhlobonhlobo zokuzindla okuqondisiwe ezingakusiza ufunde futhi usebenzise amasu e-Redikall.
Izifundo: I-iSolveLife ikunikeza izifundo eziku-inthanethi ezikufundisa izisekelo ze-Redikall nokuthi ungazisebenzisa kanjani empilweni yakho.
Umphakathi: I-iSolveLife inikeza umphakathi wabantu abanentshisekelo yokufunda nokuzijwayeza i-Redikall. Ungakwazi ukuxhumana namanye amalungu omphakathi ukuze wabelane ngolwazi lwakho futhi ufunde komunye nomunye.
Ukuhlela isikhathi somuntu siqu: Hlela izikhathi zomuntu siqu nochwepheshe be-Redikall ukuze uthole ukuqondiswa komuntu siqu nokusekelwa.
Ukubhaliswa komcimbi neshabhu: Bhalisela imicimbi ezayo ye-Redikall nama-workshops ukuze ufunde amakhono amasha futhi uxhumane nomphakathi.
Ibhulogi: Funda izindatshana nokuthunyelwe kwebhulogi mayelana ne-Redikall kanye nentuthuko yomuntu siqu.
Isitolo: Thenga amabhuku e-Redikall, izifundo, neminye imikhiqizo esitolo sangaphakathi nohlelo.
Ngokuhlangene, i-iSolveLife ne-Redikall ingasiza abantu ukuthi:
* Thuthukisa impilo yabo nokuphila kahle
* Yenza izinqumo ezingcono
* Thola ukuxhumana okungokomoya okukhulu
* Thuthukisa ukugxila kwabo nokugxilisa ingqondo
* Thuthukisa ubudlelwano babo
* Ukufinyelela inqubekelaphambili yomsebenzi kanye nezezimali
* Khulisa amazinga abo amandla
* Jabulela ukuphila ngokugcwele
Nazi izibonelo ezithile zokuthi i-iSolveLife ne-Redikall zingasetshenziswa kanjani ndawonye:
* Umuntu onenkinga yezempilo angasebenzisa i-Redikall ukuze abone futhi axazulule izinkinga ezingokomzwelo nezingokomoya ezingase zibe nomthelela ekuguleni kwakhe. I-iSolveLife ingabanikeza amathuluzi nezinsiza zokusekela inqubo yabo yokwelapha.
* Umuntu obhekene nesinqumo esinzima angasebenzisa i-Redikall ukuze athole ukucaciseleka nokuqonda ngesimo sakhe. I-iSolveLife ingabanikeza isiqondiso nokusekelwa njengoba benza isinqumo sabo.
* Umuntu ofuna ukujulisa ukuxhumana kwakhe ngokomoya angasebenzisa i-Redikall ukuze afinyelele ubuyena obuphakeme futhi athole isiqondiso kusuka ekuhlakanipheni kwakhe kwangaphakathi. I-iSolveLife ingabanikeza izinsiza kanye nokusekelwa ekukhuleni kwabo ngokomoya.
* Umuntu olwela ukugxila nokugxilisa ingqondo angasebenzisa i-Redikall ukuze ahlonze futhi abhekane nezimbangela eziyisisekelo zokuphazamiseka kwabo. I-iSolveLife ingabanikeza amathuluzi nezinsiza ukuze bathuthukise ukugxila kwabo nokugxilisa ingqondo.
* Umuntu ozabalaza ebudlelwaneni bakhe angasebenzisa i-Redikall ukuze abone futhi axazulule izinkinga eziwumsuka ezingase zibangele ukungqubuzana. I-iSolveLife ingabanikeza amathuluzi nezinsiza ukuze bathuthukise ukuxhumana kwabo futhi bakhe ubudlelwano obuqinile.
* Umuntu ofuna ukuthola umsebenzi kanye nempumelelo yezezimali angasebenzisa i-Redikall ukuze ahlonze futhi anqobe izinkolelo ezinomkhawulo okungenzeka zibabambezele. I-iSolveLife ingase ibanikeze amathuluzi nezinsiza zokubeka nokufeza imigomo yabo.
* Umuntu ozizwa ekhathele futhi ephelelwa amandla angasebenzisa i-Redikall ukuze ahlonze futhi abhekane nezimbangela zamazinga aphansi wamandla akhe. I-iSolveLife ingase ibanikeze amathuluzi nezinsiza zokwandisa amazinga abo amandla nobungqabavu.
* Umuntu ofuna ukujabulela ukuphila ngokugcwele angasebenzisa i-Redikall ukuze abone futhi akhulule noma yimiphi imizwa engemihle noma imicabango engase imbambezele. I-iSolveLife ingabanikeza amathuluzi nezinsiza ukuze baphile impilo ejabulisayo negculisayo.
Sekukonke, i-iSolveLife ene-Redikall iyinhlanganisela enamandla engasiza abantu ukuthi bafinyelele amandla abo agcwele futhi baphile izimpilo zabo ezihamba phambili.
Kubuyekezwe ngo-
Aga 5, 2025